OraVerse FDA Approval History
FDA Approved: Yes (First approved May 9, 2008)
Brand name: OraVerse
Generic name: phentolamine mesylate
Dosage form: Injection
Company: Novalar Pharmaceuticals, Inc.
Treatment for: Reversal of Anesthesia
OraVerse is a dental anesthetic reversal agent that accelerates the return to normal sensation and function following dental procedures.
Development timeline for OraVerse
| Date | Article |
|---|---|
| May 12, 2008 | Approval Novalar Pharmaceuticals, Inc. Receives FDA Approval for OraVerse |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
